1W Return
1M Return
6M Return
1Y Return
3Y Return
Start SIP in ANG Lifesciences India
ANG Lifesciences India Stock Performance
52 Week Low - High
Today’s Low - High
Open
Prev. Close
Total Traded Value
ANG Lifesciences India Fundamental
Market Cap (in crs)
Face Value
Turnover (in lacs)
Key Metrics
Qtr Change %
57.21% Fall from 52W High
-31.4
Dividend yield 1yr %
0
ANG Lifesciences India Key Financials
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
ANG Lifesciences India Quarterly Revenue
| Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|
24.73 Cr | 32.88 Cr | 18.41 Cr | 37.84 Cr | 18.55 Cr |
ANG Lifesciences India Yearly Revenue
| Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|
146.81 Cr | 229.61 Cr | 355.2 Cr |
ANG Lifesciences India Quarterly Net Profit/Loss
| Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|
-5.19 Cr | -2.09 Cr | -3.07 Cr | -3.65 Cr | -5.93 Cr |
ANG Lifesciences India Yearly Net Profit/Loss
| Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|
-10.14 Cr | -0.26 Cr | 40.32 Cr |
ANG Lifesciences India Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
Current Price
5Day EMA
27.00
10Day EMA
27.30
12Day EMA
27.30
20Day EMA
27.60
26Day EMA
28.00
50Day EMA
30.30
100Day EMA
34.90
200Day EMA
41.80
5Day SMA
27.00
10Day SMA
27.40
20Day SMA
27.20
30Day SMA
26.90
50Day SMA
29.80
100Day SMA
36.60
150Day SMA
40.40
200Day SMA
42.90
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 3129 Rs | 3129 Rs |
Week Rs | 4287 Rs | 4287 Rs |
Month Rs | 7688 Rs | 7693 Rs |
Resistance & Support
26.65
Pivot
Resistance
First Resistance
27.69
Second Resistance
28.54
Third Resistance
29.58
Support
First Support
25.80
Second support
24.76
Third Support
23.91
Relative Strength Index
43.39
Money Flow Index
47.86
MACD
-0.65
MACD Signal
-0.80
Average True Range
1.98
Average Directional Index
26.51
Rate of Change (21)
17.92
Rate of Change (125)
-40.29
Similar stocks
Similar Stocks
Peer comparison
Compare
| Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
35.06 | 21.03 | 62.75 | 26.59 | -5.69% | 18.18% | -43.52% | -52.89% | -86.96% | 0.00% | 0.00 | 40.74 | 0.48 | ||
Gujarat Terce Laboratories Ltd. | 54.26 | - | - | - | - | - | - | - | - | - | - | - | - | |
Gujarat Inject (Kerala) Ltd. | 20.98 | - | - | - | - | - | - | - | - | - | - | - | - | |
31.33 | 30 | 78.48 | 32.82 | -1.51% | 11.63% | -40.37% | -40.27% | -44.25% | 0.00% | 0.00 | 40.74 | 1.25 | ||
Vilin Bio Med Ltd. | 28.00 | - | - | - | - | - | - | - | - | - | - | - | - | |
Mono Pharmacare Ltd. | 23.90 | - | - | - | - | - | - | - | - | - | - | - | - | |
Medicamen Organics Ltd. | 28.35 | - | - | - | - | - | - | - | - | - | - | - | - |
ANG Lifesciences India Company background
Founded in: 2006
Managing director: Rajesh Gupta
ANG Lifesciences India Limited was originally incorporated as a Private Limited Company with the name ANG Lifesciences India Private Limited on June 14, 2006. On conversion into Public Limited Company, the name was changed to ANG Lifesciences India Limited on March 02, 2010. The Company further converted into Private Limited Company and the name of the Company was changed to ANG Lifesciences India Private Limited on September 22, 2010. Subsequently, on conversion into Public Limited Company, the name again changed to ANG Lifesciences India Limited on May 18, 2016.The Company is engaged in the business of manufacturing and marketing of finished pharmaceutical formulation in the form of Sterile Dry Powder Injection Vials. In 200809, the Company started its commercial production. In 201415, it commenced direct sale of medicines covering hospitals , Doctors through stockists. The Company is ISO9001:2008 certified, which manufacture its products in compliance with GMP requirements. Company has dedicated area, machinery, facilities and advanced equipment for manufacturing of Beta Lactum Non Beta Lactum products as per GMP norms. The Company currently operates a strong manufacturing setup consisting of 4 formulation plants situated at Baddi, Himachal Pradesh. These stateofart facilities have integrated process development teams with inhouse engineering capabilities and well equipped with quality control laboratories with most modern and validate analytical equipment. It also has geographical presence across India, Africa, Gulf countries other ROW countries.In August, 2017, the Company came up with a Public Issue of 15,00,800 Equity Shares by raising money from public aggregating to Rs 12 Crore. The Company acquired Mansa Printers Publishers Limited in April, 2021 for backward integration in pharma packaging to optimize costs and ensure timely availability of packaging products.
ANG Lifesciences India FAQs
How to buy ANG Lifesciences India shares?
You can easily buy ANG Lifesciences India shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
Please be aware that ANG Lifesciences India stock prices are subject to continuous fluctuations due to various factors.
Open Demat Account
